iBalt

Veröffentlicht von: Balt

Beschreibung

Throughout its history, Balt has been at the forefront of innovation in the field of Interventional Neuroradiology.

Today, the breadth of its products portfolio echoes the expertise the company has built up over several decades. It is important for Balt to present its assets to Healthcare professionals via a single mobile application: iBalt.

The iBalt application combines technical information related to products usage, compatibilities & practical tools.

• The iBalt app presents Balt's portfolio : to inform about the compatibility of each Balt’s product, set up a secure private space for healthcare professionals and provide (restricted) access to technical product information.
• The iBalt app has a compatibility function : to find the inner diameters, outer diameters, and lengths of access products to make your day-to-day work easier.
• The iBalt app offers an easy-to-use unit’s converter : to instantly check the proper compatibilities of interventional neuroradiology devices in French, inch, and millimeter,

If you are a healthcare professional you can register to the app and sign in to have access to restricted information.

The application has an off-line functionality, you can use it even without connection.

BALT is one of the world leader in the design and manufacture of Interventional Neuroradiology devices to treat neurovascular pathologies (strokes, aneurysms, arteriovenous malformations, etc.). By placing innovation at the center of its model, the company maintains its leading position in the Neuroradiology field worldwide.

The success of BALT relies on the originality of several key assets:
• Sustainable industry recognition and industrial partnerships to serve the healthcare community and patients.
• Strong and ongoing innovation to meet the expectations of the medical community: BALT’s many innovations are testimonies to the company’s major influence on the progress of Interventional Neuroradiology. They include the flow-dependent microcatheter (MAGIC, 1987), as well as the intracranial braided stent (LEO in 2003 and LEO+ in 2007 and LEO+Baby in 2012), the stentriever (CATCH in 2005, CATCH+ in 2012 and CATCHVIEW in 2018) and the flow-diverter (SILK in 2006, SILK+ in 2012, SILK VISTA BABY in 2018 and SILK VISTA in 2020).
• Multidisciplinary crossover talents: in its search for the highest performing neuroradiology products, BALT has always promoted a cross-innovation approach based on complementary expertise and disciplines. From chemistry to micromechanics, the production cycle is based on interdisciplinarity and constantly pursues end-product excellence.
Ausblenden Mehr anzeigen...

Screenshots

iBalt Häufige Fragen

  • Ist iBalt kostenlos?

    Ja, iBalt ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist iBalt seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet iBalt?

    iBalt ist kostenlos.

  • Wie hoch ist der Umsatz von iBalt?

    Um geschätzte Einnahmen der iBalt-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung

5 von 5

1 Bewertungen in Brasilien

5 star
1
4 star
0
3 star
0
2 star
0
1 star
0
Bewertungsverlauf

iBalt Bewertungen

Review

Sandeep 1986 on

Indien

Wonderful application 👍 Nicely crafted & compiled complex information in a single place 👌 Kudos to Balt for developing this application 👏👏👏

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

iBalt Installationen

Letzte 30 Tage

iBalt Umsatz

Letzte 30 Tage

iBalt Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von iBalt mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.

App-Informationen

Kategorie
Medical
Herausgeber
Balt
Sprachen
Letzte Veröffentlichung
2.1.4 (vor 1 Monat )
Veröffentlicht am
Jul 9, 2021 (vor 3 Jahren )
Zuletzt aktualisiert
vor 6 Tagen
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.